New CDC Opioid Guidelines: Too Little, Too Late for Chronic Pain Patients?
By Sam Whitehead and Andy Miller for Kaiser Health News on March 15, 2023 Jessica Layman estimates she has called
Read More
Part D/Prescription Drugs
Covering new weight loss drugs could strain Medicare, policy experts warn
By Elaine Chen for Stat News on March 11, 2023 The emergence of highly effective obesity drugs has spurred renewed efforts to
Read MoreHit with that extra premium for Medicare?
The Medicare Income-Related Monthly Adjustment Amount (IRMAA) is an amount you may pay in addition to your Part B or
Read MoreWhy Does Insulin Cost So Much? Big Pharma Isn’t the Only Player Driving Prices
(By Arthur Allen for Kaiser Health News) Eli Lilly & Co.’s announcement that it is slashing prices for its major
Read More5 Ozempic updates
(By Paige Twenter for Becker’s Hospital Review) Ozempic, a diabetes treatment that has caught the attention of Elon Musk, TikTokers
Read MoreBiden proposes expanding Medicare drug negotiation program
(By Rachel Cohrs for STAT) WASHINGTON — The Biden administration will propose expanding Democrats’ new drug pricing law by allowing
Read MoreCMS Drug Spending Dashboards and the Inflation Reduction Act
(Source – www.cms.gov/blog) The Centers for Medicare & Medicaid Services released the annual update to the Drug Spending Dashboards with
Read MoreFDA has new leverage over companies looking for a quicker drug approval
(By Sydney Lupkin for NPR) The huge spending bill that became law last December also included fixes to a problem
Read MoreMore insurance brokers would choose traditional Medicare over Medicare Advantage: Report
(By Rylee Wilson for Becker’s Hospital Review) More insurance brokers said they would enroll in traditional Medicare over Medicare Advantage
Read MoreEli Lilly cuts the price of insulin, capping drug at $35 per month out-of-pocket
(By The Associated Press published by NPR) Eli Lilly will cut prices for some older insulins later this year and
Read More